Document:

Exhibit 10.18

 

Grant No. [•]

 

SIGNAL GENETICS, INC.

 

RESTRICTED STOCK UNIT GRANT AGREEMENT

UNDER THE 2014 STOCK INCENTIVE PLAN

 

This Restricted Stock
Unit Grant Agreement (this “Grant Agreement”), is made and entered into as of the date of grant set forth below
(the “Date of Grant”) by and between Signal Genetics, Inc., a Delaware corporation (the “Company”),
and the participant named below (the “Participant”). Capitalized terms not defined herein have the meanings
ascribed to them in the Signal Genetics, Inc. 2014 Stock Incentive Plan (the “Plan”).
Where the context permits, references to the Company include any successor to the Company.

 

	Name of Participant:	Samuel D. Riccitelli
	 	 
	Social Security No.:	[·]

 

	Address:	[·]

 

Number of Restricted Stock Units (“RSUs”):  
[·]

 

	Date of Grant:	[·]

 

Vesting Schedule and Payment Dates:

 

	Percentage of the RSU 
Award Vesting	 	Vesting Date	 	Payment Date
	33-1/3%	 	The Date of Grant	 	January 1, 2015
	16-2/3%	 	January 1, 2015	 	Vesting Date
	16-2/3%	 	One year anniversary of the Date of Grant	 	Vesting Date
	16-2/3%	 	Eighteen month anniversary of the Date of Grant	 	Vesting Date
	16-2/3%	 	Two year anniversary of the Date of Grant	 	Vesting Date

 

1.          Grant
of RSU Award. The Company hereby grants to the Participant the total number of Restricted Stock Units set forth above (the
“RSUs”), subject to all of the terms and conditions of this Grant Agreement and the Plan. Each vested RSU entitles
the Participant to receive the Fair Market Value of a share of Common Stock, as determined at the Payment Date, and payable as
described in Paragraph 3.

 

2.          Vesting.
The RSU Award will vest in accordance with the Vesting Dates set forth above only if the Participant remains in continuous service
with the Company as of such date and has not received a notice of termination from the Company prior to such date. Upon the Participant’s
termination from employment for any reason prior to the applicable Vesting Date, with or without cause or by mutual agreement,
the right to vest in any remaining RSUs under this Award will terminate and any unvested portion of the Participant’s RSUs
will be forfeited and cancelled. Notwithstanding any provisions to the contrary, upon a Change of Control that occurs following
the Date of Grant while the Participant remains in continuous service with the Company, the Participant shall become fully vested
in all RSUs remaining unvested as of such date, and the Change in Control date shall be treated as the Vesting Date and Payment
Date for any such RSUs.

 

    	 

    	 

    

 

3.          Time
and Form of Payment. This RSU Award represents an unfunded, unsecured promise by the Company to: (i) deliver as of the applicable
Payment Date a number of shares of Common Stock (the “Shares”) equal to the number of vested RSUs, (ii) pay
an amount in cash equal to the product of the Fair Market Value of the Common Stock on the Payment Date and the number of RSUs
vesting on the associated Vesting Date, or (iii) provide some combination of Shares and cash as referenced in (i) and (ii), respectively;
all as determined by the Administrator in its sole discretion as of each Payment Date. Settlement of vested RSUs shall be made
on or as soon as administratively practicable after the Payment Date.

 

4.          Transferability.
The RSUs issued pursuant to this Grant Agreement may not be assigned, transferred, hypothecated, or encumbered, in whole or in
part, either directly or by operation of law or otherwise, including, but not limited to, by execution, levy, garnishment, attachment,
pledge, bankruptcy, or in any other manner, except transfer by will or by the laws of descent and distribution. All rights with
respect to the RSUs shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s
guardian or legal representative.

 

5.          No
Stockholder Rights Prior to Settlement. The Participant shall have no rights as a stockholder with respect to any Shares represented
by the RSUs until the date of issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a
duly authorized transfer agent of the Company), if applicable. Unless otherwise required by the Plan, no adjustment shall be made
for dividends, distributions, or other rights for which the record date is prior to the date, if any, that Shares are issued.

 

6.          Grant
Agreement Subject to Plan. This Grant Agreement is made pursuant to all of the provisions of the Plan, which is incorporated
herein by this reference, and is intended, and shall be interpreted in a manner, to comply therewith. In the event of any conflict
between the provisions of this Grant Agreement and the provisions of the Plan, the provisions of the Plan govern.

 

7.          No
Employment or Other Rights. Nothing in the Plan or this Grant Agreement confers upon the Participant any right to continue
in the employ of the Company or any Affiliate or will interfere with or restrict the right of the Company or its shareholders (or
of an Affiliate or its shareholders, as the case may be) to terminate the Participant’s employment or services any time for
any reason whatsoever, with or without cause. Participation in the Plan is voluntary. The grant of this RSU Award does not create
any contractual or other right to receive any subsequent Award under the Plan; future grants, if any, will be at the sole discretion
of the Company. Further, the value of the RSU Award is an extraordinary item of compensation, which is not part of the Participant’s
normal or expected compensation for purposes of any benefit plan or program of the Company (unless such plan or program specifically
provides otherwise).

 

8.          Tax
Withholding. The Company is entitled to require a cash payment by or on behalf of the Participant and/or to withhold an appropriate
number of Shares (to be determined utilizing the Fair Market Value of such Shares on the Payment Date) from any RSUs granted hereunder
or deduct from other compensation payable to the Participant to satisfy any sums required by federal, state, or local tax law to
be withheld or to satisfy any applicable payroll deductions with respect to the vesting of, lapse of restrictions on, or settlement
of any RSU Award. The Company may refuse to issue Shares or deliver cash if the Participant fails to make appropriate accommodation
for his or her tax obligations.

 

9.          No
Compensation Deferral. The RSUs are not intended to constitute
“nonqualified deferred compensation” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended,
and as such, settlement of vested RSUs shall be made no later than the fifteenth day of the third calendar month of the calendar
year following the applicable Vesting Date.

 

    	2

    	 

    

 

10.        Notices.
Any document relating to participation in the Plan or any notice required or permitted hereunder shall be given in writing and
shall be deemed effectively given upon personal delivery or upon deposit in the U.S. Post Office or foreign postal service, by
registered or certified mail, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed
to the other party at the address of such party set forth in this Grant Agreement or at such other address as such party may designate
in writing from time to time to the other party. The Company may, in its sole discretion, decide to deliver any documents related
to current or future participation in the Plan by electronic means or request the Participant’s consent to participate in
the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate
in the Plan through any online or electronic system established and maintained by the Company or another third party designated
by the Company.

 

11.        Tax
and Legal Advice. The Participant acknowledges that he or she has had the opportunity to seek the advice of counsel and other
personal advisers, and that the Company has provided no advice to or made warranties or representations with respect to the tax
consequences of the transactions contemplated by this Grant Agreement or the economic or other impacts to the Participant of the
arrangements contemplated hereby. The Participant is in no respect relying on the Company or its representatives for an assessment
of such tax, legal, economic, or other consequences.

 

12.        Entire
Grant Agreement; Waiver of Awards Prior to Date of Grant. This Grant Agreement and the Plan contain the entire agreement and
understanding between the parties as to the subject matter hereof. No amendment or modification hereof shall be valid unless it
is in writing and signed by the parties hereto. Further, by accepting this Award, the Participant hereby forever waives and releases
any and all rights the Participant has or may have, actually or allegedly, to any equity award or equity incentive (or any cash
award derived from or determined by reference to equity value) under any plan, program, or agreement of the Company or its predecessor
entered into prior to the Date of Grant, including but not limited to the award described in the Incentive Units Agreement dated
October 31, 2012 between the Participant and Signal Genetics, LLC and the Employment Agreement dated October 31, 2012 between the
Participant and Signal Genetics, LLC. The Participant hereby acknowledges and agrees that he has read this provision and understands
its effect and implications.

 

13.        Acceptance.
By accepting this Award, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is
familiar with this Grant Agreement, the Plan, and a prospectus for the Plan prepared in connection with the registration of the
Common Stock to be issued pursuant to the Plan with the Securities and Exchange Commission (the “Plan Prospectus”),
(b) acknowledges that the RSU Award is subject to all of the terms and conditions of this Grant Agreement and the Plan, and
(c) agrees to accept as binding, conclusive, and final all decisions or interpretations of the Administrator on any questions
arising under the Grant Agreement or the Plan.

 

IN WITNESS WHEREOF,
the parties have executed this Grant Agreement as of the date first written above.

 

	SIGNAL GENETICS, INC.	 	PARTICIPANT
	 	 	 	 	 
	By:	 	 	 
	 	Bennett S. LeBow	 	Samuel D. Riccitelli
	 	Chairman of the Board of Directors	 	Date:	 
	 	667 Madison Ave., 14th Floor	 	 	 
	 	New York,  NY 10065	 	 	 

 

    	3Exhibit 10.19

 

	University of Arkansas for Medical Sciences

4301 West Markham Street #632 

Little Rock, AR 72205-7199	

 

	
        WBowes@uams.edu

         

        

        Phone      501 686-5671

        Fax          501 686-8137
	
        William R. Bowes, CFO      

        Vice Chancellor for Finance &

        Administration

 

March 18, 2014

 

Sam Riccitelli

Signal Genetics, LLC

667 Madison Avenue 14th Floor

New York, NY 10065

 

Dear Mr. Riccitelli,

 

The purpose of this letter agreement is to state the terms under
which the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences
("UAMS") and Signal Genetics, LLC will act regarding the "Reference Laboratory Services Agreement" and the
"Reference Laboratory Services Agreement for Research Specimens" both effective on March 21, 2011, and amendment. The
agreements and amendment are attached for your reference. These two agreements expire on March 20, 2014. The parties have not provided
notice that the agreements will be renewed per the agreements. UAMS intends to continue receiving services from Signal Genetics,
LLC, and believes it is in its best interest to continue receiving the laboratory services in accordance with the agreements for
the next sixty (60) days during which time new and current agreements can be prepared and executed between the parties.

 

Therefore, the parties agree that the terms of the aforementioned
agreements shall remain in full force and effect for the next sixty (60) days. This sixty (60) day time frame will allow for new
agreements to be prepared and executed. The parties further agree that the agreements entered into on March 21, 2011 and extended
for sixty (60) days by this letter shall expire on May 20, 2014.

 

If this letter agreement correctly reflects the terms agreed
to by Signal Genetics, LLC, please sign a copy of this agreement in the space provided below and return it by facsimile to the
facsimile number of UAMS stated above and by overnight courier to the address of UAMS stated above, in each case to the attention
of William R. Bowes.

 

Respectfully,

  

	/s/ William R. Bowes	3/19/2014	 	/s/ Sam Riccitelli	3/19/2014
	William R. Bowes, CFO	Date	 	Sam Riccitelli,	Date
	Vice Chancellor for Finance & Administration	 	 	Signal Genetics, LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]